Living with type 1 diabetes is a daily struggle that can prove stressful and exhausting. In addition, it can turn into a vicious circle that leads to a lack of motivation, poorer glycemic control, a greater risk of diabetes-related complications and a decreased quality of life. “Diabetes is unique as a disease because the self-management … Read more
The annual ATTD conference (Advanced Technologies & Treatment for Diabetes) was held from February 19 to 22, 2020 in Madrid (Spain). This conference presents the latest research in terms of technologies and therapies for the treatment of diabetes. Here is some news that caught the attention of the BETTER team: A new artificial pancreas in … Read more
For over a year now, people in Quebec who are living with type 1 diabetes and who are insured with the RAMQ (Régie de l’assurance maladie du Québec) can no longer start their treatment using Lantus® (long-acting insulin). People starting on long-acting insulin are now required to use the generic (or biosimilar) version of Lantus®, … Read more
Latent autoimmune diabetes in adults (LADA), also called “slow-onset type 1 diabetes,” is often misdiagnosed from the start. Since LADA develops later in life than typical type 1 diabetes (generally after the age of 30), front-line healthcare professionals often mistake it for type 2 diabetes. In fact, in LADA, as in type 1 diabetes, antibodies … Read more
An increasing number of people living with insulin-treated diabetes use or want to use continuous glucose monitoring systems. One of these systems, the FreeStyle Libre, has been covered under the RAMQ in Quebec since July 2019 under certain conditions, allowing more people to have access to this technology. The FreeStyle Libre is a Flash glucose … Read more